Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Clinical trial NCT05532943 · RECRUITING
Trial details
- NCT number
- NCT05532943
- Sponsor
- Ever Supreme Bio Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2028-10-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.